ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,048Medicare Part D Prescriptions Filled, Including Refills

Rank: 534 out of 3001

$727K Total Retail Price of All Prescriptions

Rank: 266 out of 3001

433 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
48% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 433 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

13% of this provider’s 433 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 6,203 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$80 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
HYDROCODONE-ACETAMINOPHEN 396 234 S3 1 7
LISINOPRIL 248 180 2 2
SIMVASTATIN 222 155 3 1
OMEPRAZOLE 193 135 4 4
LEVOTHYROXINE SODIUM 191 137 5 3
METOPROLOL TARTRATE 172 109 6 8
FUROSEMIDE 158 125 7 6
LISINOPRIL-HYDROCHLOROTHIAZIDE 141 124 8 22
TRAMADOL HCL 139 102 9 17
METFORMIN HCL 132 85 10 9
OXYCODONE-ACETAMINOPHEN 131 76 S2 11 32
GABAPENTIN 127 92 12 14
PREDNISONE 126 96 13 39
AMLODIPINE BESYLATE 121 84 14 5
AZITHROMYCIN 119 103 15 36
WARFARIN SODIUM 119 92 15 12
FLUOXETINE HCL 102 78 17 61
METOPROLOL SUCCINATE 96 77 18 19
MELOXICAM 94 68 19 34
GLIMEPIRIDE 93 85 20 31
TRAZODONE HCL 91 44 21 37
CARVEDILOL 85 70 22 25
TAMSULOSIN HCL 85 77 22 29
ZOLPIDEM TARTRATE 84 55 24 24
LOVASTATIN 75 66 25 38
OXYCODONE HCL-ACETAMINOPHEN 71 16 S2 26 81
NEXIUM 70 46 27 23
ROPINIROLE HCL 69 63 28 88
PANTOPRAZOLE SODIUM 69 52 28 43
ALENDRONATE SODIUM 65 55 30 26
METHYLPREDNISOLONE 65 50 30 121
CLOPIDOGREL 64 50 32 28
LEVOFLOXACIN 64 54 32 115
SERTRALINE HCL 63 22 34 20
NAMENDA 63 37 34 40
HYDROCHLOROTHIAZIDE 61 51 36 10
NITROFURANTOIN MONO-MACRO 60 48 37 158
ISOSORBIDE MONONITRATE ER 59 42 38 45
ADVAIR DISKUS 59 56 38 58
ATORVASTATIN CALCIUM 59 42 38 11
CYMBALTA 59 26 38 53
TRIAMTERENE-HCTZ 57 54 42 48
POTASSIUM CHLORIDE 57 46 42 15
VENLAFAXINE HCL 56 21 44 171
ALPRAZOLAM 55 52 45 98
NYSTOP 54 24 46 167
LYRICA 53 30 47 87
PRAVASTATIN SODIUM 53 41 47 13
DONEPEZIL HCL 52 50 49 27
CITALOPRAM HBR 52 35 49 16
CEPHALEXIN 51 28 51 86
OXYCODONE HCL 50 13 S2 52 72
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 16, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.